A Streamlined High-Throughput Plasma Proteomics Platform for Clinical Proteomics with Improved Proteome Coverage, Reproducibility, and Robustness
Journal of the American Society for Mass Spectrometry · 2023-04-05 · 34 (4) · 754-762
DOI: 10.1021/jasms.3c00022 ↗At a glance
Journal article in Journal of the American Society for Mass Spectrometry, published online on 2023-03-28. Written by Jongmin Woo and 1 co-authors. Institution: Center for Translational Biomedical Research, University of North Carolina at Greensboro, North Carolina Research Campus, Kannapolis, North Carolina …. Major MEDLINE topics: Proteomics, Proteome. Cited 33 times so far (Crossref); 42 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (original language)
Mass spectrometry-based clinical proteomics requires high throughput, reproducibility, robustness, and comprehensive coverage to serve the needs of clinical diagnosis, prognosis, and personalized medicine. Oftentimes these requirements are contradictory to each other. We report the development of a streamlined High-Throughput Plasma Proteomics (sHTPP) platform for untargeted profiling of the blood plasma proteome, which includes 96-well plates and simplified procedures for sample preparation, disposable trap column for peptide loading, robust liquid chromatographic system for separation, data-independent acquisition in tandem mass spectrometry, and DIA-NN, FragPipe, and in-house peptide spectral library-based data analysis. Using the optimized platform at a throughput of 60 samples per day, over 600 protein groups including 57 FDA-approved biomarkers can be consistently identified from whole human plasma, and more than 85% of the detected proteins have 100% completeness in quantitative values across 300 samples. The balance achieved between proteome coverage, throughput, and reproducibility of this sHTPP platform makes it promising in clinical settings, where a large number of samples are to be measured quickly and reliably to support various needs of clinical medicine.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Center for Translational Biomedical Research, University of North Carolina at Greensboro, North Carolina Research Campus, Kannapolis, North Carolina 28081, United States.
- Department of Chemistry & Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina 27402, United States.
ORCID profiles: Qibin Zhang
Funding
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Cite
APA
Woo, J., & Zhang, Q. (2023). A Streamlined High-Throughput Plasma Proteomics Platform for Clinical Proteomics with Improved Proteome Coverage, Reproducibility, and Robustness. Journal of the American Society for Mass Spectrometry, 34(4), 754-762. https://doi.org/10.1021/jasms.3c00022
Vancouver
Woo J, Zhang Q. A Streamlined High-Throughput Plasma Proteomics Platform for Clinical Proteomics with Improved Proteome Coverage, Reproducibility, and Robustness. Journal of the American Society for Mass Spectrometry. 2023;34(4):754-762. doi:10.1021/jasms.3c00022
BibTeX
@article{Woo2023,
author = {Woo, Jongmin and Zhang, Qibin},
title = {A Streamlined High-Throughput Plasma Proteomics Platform for Clinical Proteomics with Improved Proteome Coverage, Reproducibility, and Robustness},
journal = {Journal of the American Society for Mass Spectrometry},
year = {2023},
volume = {34},
number = {4},
pages = {754--762},
doi = {10.1021/jasms.3c00022}
}
EUVIMED